AMETEK, Inc. Appoints Dean Seavers to Board of Directors, Effective from February 24, 2022
February 10, 2022 at 08:20 am EST
Share
AMETEK, Inc. announced that its Board of Directors has appointed Dean Seavers as a new director of the Company effective February 24, 2022. Mr. Seavers most recently served as President and Executive Director for National Grid, a leading provider of electricity, natural gas, and clean energy solutions. Mr. Seavers served as President and Executive Director at National Grid from 2015 through 2020, where he led an impressive transformation including leading their clean energy and decarbonization initiatives.
Previously, Mr. Seavers served as Chief Executive Officer at Red Hawk Fire & Security and at GE Security. He has also held leadership positions at United Technologies and Tyco International.
AMETEK, Inc. is one of the world's leaders in manufacturing and marketing electronic instruments and electromechanical devices. Net sales break down by family of products as follows:
- electronic instruments (70.1%): instruments and screens for aircrafts cockpits, airborne electronic systems of data surveillance and registering, pressure, temperature and flow sensors for airline companies and aeronautical manufacturers, analysis devices for the medical and research sectors, measurement and surveillance instruments used in the processing industries, instruments and dashboards for heavy trucks and agricultural vehicles, etc.;
- electromechanical devices (29.9%): brushless motors, heat exchangers, connectors, terminals, thermal management subsystems, motors-blowers, etc. primarily for the aeronautic, automotive, medical, computing and defense sectors. The group also provides metal powders and alloys for the manufacturing of electronic components and automotive and aeronautic products.
At the end of 2023, the group had more than 150 production sites worldwide.
Net sales are distributed geographically as follows: United States (52.6%), Asia (20.9%), United Kingdom (3.3%), European Union (14.3%) and others (8.9%).